1. Home
  2. VYGR vs INBK Comparison

VYGR vs INBK Comparison

Compare VYGR & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • INBK
  • Stock Information
  • Founded
  • VYGR 2013
  • INBK 1999
  • Country
  • VYGR United States
  • INBK United States
  • Employees
  • VYGR N/A
  • INBK N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • INBK Major Banks
  • Sector
  • VYGR Health Care
  • INBK Finance
  • Exchange
  • VYGR Nasdaq
  • INBK Nasdaq
  • Market Cap
  • VYGR 165.5M
  • INBK 196.2M
  • IPO Year
  • VYGR 2015
  • INBK N/A
  • Fundamental
  • Price
  • VYGR $2.74
  • INBK $24.25
  • Analyst Decision
  • VYGR Strong Buy
  • INBK Buy
  • Analyst Count
  • VYGR 8
  • INBK 4
  • Target Price
  • VYGR $14.33
  • INBK $34.50
  • AVG Volume (30 Days)
  • VYGR 377.3K
  • INBK 56.3K
  • Earning Date
  • VYGR 05-06-2025
  • INBK 07-23-2025
  • Dividend Yield
  • VYGR N/A
  • INBK 0.99%
  • EPS Growth
  • VYGR N/A
  • INBK 27.37
  • EPS
  • VYGR N/A
  • INBK 2.40
  • Revenue
  • VYGR $66,958,000.00
  • INBK $114,609,000.00
  • Revenue This Year
  • VYGR N/A
  • INBK $5.36
  • Revenue Next Year
  • VYGR $45.34
  • INBK $17.09
  • P/E Ratio
  • VYGR N/A
  • INBK $10.11
  • Revenue Growth
  • VYGR N/A
  • INBK 20.13
  • 52 Week Low
  • VYGR $2.65
  • INBK $19.54
  • 52 Week High
  • VYGR $9.55
  • INBK $43.27
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 33.88
  • INBK 51.82
  • Support Level
  • VYGR $2.71
  • INBK $23.19
  • Resistance Level
  • VYGR $2.99
  • INBK $24.88
  • Average True Range (ATR)
  • VYGR 0.18
  • INBK 0.71
  • MACD
  • VYGR -0.05
  • INBK 0.11
  • Stochastic Oscillator
  • VYGR 10.86
  • INBK 50.00

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

Share on Social Networks: